EQS-News: innoscripta SE Launches Expansion into the United Kingdom
|
EQS-News: innoscripta SE
/ Key word(s): Expansion
innoscripta SE Launches Expansion into the United Kingdom
Tutzing, 29 July 2026 – innoscripta SE ("innoscripta", ISIN: DE000A40QVM8) continues its international expansion following its successful market entry into France (news release dated 15 April 2026) by launching operations in the United Kingdom. An experienced and dedicated local sales team has been established to drive growth in the market. The Company has already secured its first UK customer. A software company generating annual revenues in the mid-double-digit million euro range has selected innoscripta's SaaS platform Clusterix, which has been fully adapted to UK regulatory requirements, to support its R&D tax relief claims. Clusterix enables companies to systematically capture R&D projects, working hours and eligible costs while creating a comprehensive, audit-ready documentation trail. This provides a significant advantage as HM Revenue & Customs (HMRC) has substantially tightened its documentation and compliance requirements for R&D tax relief claims in recent years. Several additional customer engagements are currently at an advanced stage of negotiations. innoscripta plans to significantly expand both its UK sales organisation and customer base by the end of the year. With annual R&D tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP), the United Kingdom represents a market roughly seven times larger than Germany and, alongside France, is one of Europe's largest R&D tax incentive markets. About innoscripta innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.
Contact innoscripta SE Max Hunger ir@innoscripta.de
Press contact edicto GmbH Ralf Droz / Svenja Liebig +49 69 905505 56 innoscripta@edicto.de
29.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | innoscripta SE |
| Bahnhofstraße 17 | |
| 82327 Tutzing | |
| Germany | |
| Phone: | +4989255553509 |
| E-mail: | info@innoscripta.com |
| Internet: | https://www.innoscripta.com |
| ISIN: | DE000A40QVM8 |
| WKN: | A40QVM |
| Listed: | Regulated Unofficial Market in Frankfurt (Scale) |
| LEI Code: | 894500BA6B025ZEF0T83 |
| EQS News ID: | 2373168 |
| End of News | EQS News Service |
|
|
2373168 29.07.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 8,46 | 19,83 | 27,27 | 39,37 | 64,71 | 103,41 | 145,00 | |
| EBITDA1,2 | 0,63 | 7,85 | 9,33 | 15,62 | 37,46 | 63,62 | 76,00 | |
| EBITDA-Margin3 | 7,47 | 39,58 | 34,21 | 39,68 | 57,89 | 61,52 | 52,41 | |
| EBIT1,4 | 0,48 | 7,73 | 9,18 | 15,47 | 37,28 | 63,42 | 85,00 | |
| EBIT-Margin5 | 5,72 | 7,73 | 9,18 | 39,29 | 57,61 | 61,33 | 58,62 | |
| Net Profit (Loss)1 | 0,29 | 4,99 | 6,10 | 10,27 | 25,09 | 42,61 | 58,00 | |
| Net-Margin6 | 3,48 | 25,15 | 22,35 | 26,09 | 38,77 | 41,20 | 40,00 | |
| Cashflow1,7 | 0,44 | 1,73 | 8,89 | 5,26 | 20,14 | 40,83 | 52,00 | |
| Earnings per share8 | 0,03 | 0,50 | 0,61 | 1,03 | 2,51 | 4,26 | 5,80 | |
| Dividend per share8 | 0,00 | 0,00 | 0,50 | 0,80 | 2,40 | 4,00 | 3,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Nexia
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Innoscripta | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A40QVM | DE000A40QVM8 | SE | 731,00 Mio € | 23.05.2025 | Kaufen | 8FWH4GVX+FJ |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 11,79 | 12,60 | 0,94 | 44,30 | 22,73 | 17,90 | 7,07 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,80 | 2,40 | 4,00 | 5,47% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 21.04.2026 | 15.05.2025 | 21.08.2025 | 03.11.2025 | 25.02.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -4,23% | -13,27% | -19,05% | -30,65% | -39,08% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
